Quarterly report [Sections 13 or 15(d)]

Schedule of Diluted Net Loss Per Share (Details)

v3.25.1
Schedule of Diluted Net Loss Per Share (Details) - shares
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Stock option 3,171,172 260,213
Equity Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Stock option 329,752 64,752